Skip to main content

Animations

MJFF Publications

7391 - 7400 of 8825 Results
Title
Year
  • Year
  • 2021
  • 2022
  • 2024
  • 2014
  • 2016
  • 2017
  • 2016
  • 2013
  • 2016
  • 2022
  • Summary Details
    OPEN
    Title: Mechanisms of VPS35-mediated neurodegeneration in Parkinson's disease
    Journal Name: International Review of Movement Disorders
    Publisher: Elsevier
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/bs.irmvd.2021.08.005
    Citation Count: 22
  • Summary Details
    RESTRICTED
    Title: Considerations for clinical trial design and conduct in the evaluation of novel advanced therapeutics in neurodegenerative disease
    Journal Name: International Review of Neurobiology
    Publisher: Elsevier
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/bs.irn.2022.09.006
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Phosphoglycerate kinase is a central leverage point in Parkinson’s disease–driven neuronal metabolic deficits
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adn6016
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1042/bj20140334
    Citation Count: 807
  • Summary Details
    OPEN
    Title: Age at onset and Parkinson disease phenotype
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000002461
    Citation Count: 352
  • Summary Details
    OPEN
    Title: Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000004609
    Citation Count: 151
  • Summary Details
    OPEN
    Title: Machine Learning Interface for Medical Image Analysis
    Journal Name: Journal of Digital Imaging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: apache-2.0
    DOI - Digital Object Identifier: 10.1007/s10278-016-9910-0
    Citation Count: 68
  • Summary Details
    RESTRICTED
    Title: Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2013.3861
    Citation Count: 367
  • Summary Details
    OPEN
    Title: Association ofGBAMutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2016.2245
    Citation Count: 223
  • Summary Details
    OPEN
    Title: Diagnostic classification of Parkinson’s disease based on non-motor manifestations and machine learning strategies
    Journal Name: Neural Computing and Applications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00521-022-07256-8
    Citation Count: 46
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.